Currently Browsing

Our Products

Capecitabine Tablets USP 150 mg – 60/Bottle

Overview

Reference Brand:
Xeloda®
Therapeutic Class:
Antimetabolite Antineoplastic Agent

Specifications

GCN:
31611
Strength:
150 mg
Size:
60
NDC #:
59651020460
TE Code:
AB

Order Information

Case Qty (min order qty):
48
Case Weight (lbs):
5.616

Attributes

Physical Form:
Tablets
Shape:
Tablets
Color:
Light Peach
Imprint:
"150"
Prescribing Info
Product News

July 15, 2026 | Aurobindo Receives FDA Approval for Etodolac Tablets USP, 400 mg and 500 mg ... Read more

Product News

June 24, 2026 | Aurobindo Receives FDA Approval for Icosapent Ethyl Capsules, 1 gram ... Read more

Product News

June 09, 2026 | Aurobindo Receives FDA Approval for Cephalexin For Oral Suspension USP, 125 mg/5 mL and 250 mg/5 mL ... Read more